A great single center review of the appropriateness of IVIG use. Hopefully will be reproduced at numerous sites. ncbi.nlm.nih.gov/pubmed/3110506…

Giving an overview of our robust translational NK cell program at Farber. Three trials in advanced stages (one open) plus two in the pipeline and several exciting projects in the lab... loving our highly collab research environment ⁦Dana-Farber⁩ ⁦⁦Harvard Medical School⁩

We have been talking about this sort of thing for a long time kevinmd.com/blog/2019/10/a…

Image of the Week: Voriconazole-Induced Periostitis nej.md/31Zd0L7

This pending #vincristineshortage is truly scary given how fundamental this drug (FDA approved 1963!) is in treatment of cancer. Not only a bedrock of treatment for childhood leukemia, it is part of the most common regimens for non-Hodgkin lymphoma (R-CHOP) & adult ALL. The Leukemia & Lymphoma Society

How Clonal Hematopoiesis of Indeterminate Potential Increases the Risk of Heart Disease and Blood Cancers as People Age - The ASCO Post ascopost.com/issues/novembe…

Chronic Myelomonocytic Leukemia: 2020 Update on Diagnosis, Risk Stratification and Management onlinelibrary.wiley.com/doi/abs/10.100… Latest on genetics, epigenetics, ARCH,O-CMML & personalized therapies Mayo Clinic Comprehensive Cancer Center Guillermo Sanz G Garcia-Manero David Steensma, MD Sanam Loghavi, MD صنم لغوی 🔬🧬 Julie Feldstein,MD Naseema Gangat

Great article about a pioneer in her field. Take note of her approach to problem-solving, and her comments about machine learning. quantamagazine.org/barbara-liskov…

Saw this at #ASH19-should not happen! Medicine has always been a trans-national profession. Remember Noah Gordon novel made into 2013 German film #DerMedicus “The Physician”? That was based on IbnSina of #Isfahan Iran where this first author is from-We forget history at our peril

The evolutionary dynamics and fitness landscape of clonal hematopoiesis science.sciencemag.org/content/367/64…

We are excited to share our new story Nature Immunology on how an adaptation of MDS HSPCs to inflammation contributes to a competitive advantage. Congrats to Tomoya Muto and the awesome team G Garcia-Manero MD Anderson Cancer Center UC San Francisco Cincinnati Children's Leukemia & Lymphoma Society Research. rdcu.be/b3FHz

Proud to be part of such a great team Rizwan Romee Dana-Farber

Thank you Alexandra! I think this therapy has great potential as a preemptive strategy to prevent post-transplant relapse. We are actively working on this

Wake up Canada! We need to invest on strategic technologies and pharma. It’s vaccine and PPE now next would be IVIG, chemotherapy drugs, CAR-T cell etc...⁦Justin Trudeau⁩ theglobeandmail.com/politics/artic…

Hi @jerrytan_tan.

Build, measure, learn #startupentrepreneur steveblank.com/2015/05/06/bui…